Wednesday, 5 October, 2022

Topic: Corbevax

DCGI approval in, but here’s why you can’t choose Corbevax as your booster just yet

Corbevax was, over the weekend, approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India.

Drug authority clears Covaxin, Corbevax for children aged 5 to 12

DGCI also allowed emergency use of Zycov-D (Zydus Cadila vaccine) for children above 12 years.

Cleared Corbevax for ages 12-14 based on interim safety & immune response data, govt tells LS

Govt was responding to question on availability of safety & efficacy data for Corbevax, and whether it had been peer-reviewed. It sidestepped queries on efficacy & peer-review.

Corbevax is India’s ‘lowest priced vaccine’, saves exchequer Rs 1500 cr, Biological E says

Hyderabad-based Biological E has priced its vaccine at Rs 990 in the private market. For the government, however, the vaccine is at just Rs 145, making it very affordable.

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

Govt panel recommends Biological E’s Corbevax for emergency use among 12 to 18-year-olds

The recommendation has been sent to Drug Controller General of India for final approval. DCGI had earlier approved Corbevax for restricted use in emergency situations for adults.

5 months after nod, ZyCov-D set for rollout in 7 states. Bihar starts getting 1st set of shots

It will be used in six other states too. Corbevax of Biological E is also expected to start coming in this month. No decision so far on the government procuring Covovax.

Corbevax, a new patent-free Covid vaccine, is an important step to end pandemic

Corbevax was developed with global vaccine access in mind. The goal was to make a low-cost, easy-to-produce and -transport vaccine.

What it will take to vaccinate the world against Covid

A Q&A with vaccine scientist Peter Hotez, author of 'Preventing the Next Pandemic', on developing a low-cost Covid vaccine, and why Omicron won’t be the end of the pandemic.

Corbevax maker says ‘too much dependence on MNCs, focus on new tech’ behind vaccine inequity

Corbevax co-developer Dr Peter Hotez says the vaccine will 'make up for lost time' in race to immunise millions and its patent was waived in the spirit of 'decolonisation'.

On Camera


The BMW i4 eDrive40. Photo Credit: BMW

Ukraine crisis gave auto sector a crude shock. See how India is responding

The PLI scheme as well as other sops for manufacturing, show that despite some public missteps, government is trying to coax manufacturing into India.

Indian refiners scout for oil deals ahead of EU ban on Russian crude imports

European Union ban on Russian crude imports from 5 Dec will drive European refiners to buy more Middle East oil, putting them in competition with Asian buyers.


Representational image | File photo of BrahMos supersonic cruise missile | ANI

IAF to increase Sukhois armed with BrahMos supersonic cruise missile with over 500km-range

The IAF currently has 40 SU-30 MKI with BrahMos, the only supersonic cruise missile in the world.

India’s hijab supporters will lose even if they win SC battle. Because the real war is political

In a highly polarised time, cornered minorities tend to lean back and protect the roots and fundamentals of what is so dear to them. Politically, it can often be a bad trap.